相关实验视频
Updated: Jul 11, 2026

05:47
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
Published on: May 13, 2015
14.4K
捐赠者-接受者年龄差异对类甲状腺移植的影响
Ayumi Arauchi1, Katsuhisa Matsuura1,2, Tatsuya Shimizu1
1Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Regenerative therapy
|December 23, 2025
概括
捐赠者与接受者的年龄不匹配影响了小鼠甲状腺移植的成功. 移植给老老老鼠的年轻的供体甲状腺显示不良移植,与相反的情况不同,突出显示了供体成熟度.
科学领域:
- 再生医学是一种再生医学.
- 内分泌学 在内分泌学.
- 移植生物学 移植生物学
背景情况:
- 再生医学为甲状腺疾病提供了一种有前途的方法,旨在用患者衍生细胞取代受损组织.
- 目前干细胞衍生甲状腺组织成熟度的局限性,需要研究替代性供体来源和移植策略.
- 了解捐赠者-接受者因素对于成功的甲状腺组织移植和功能恢复至关重要.
研究的目的:
- 为了研究捐赠者-接受者年龄差异对甲状腺全移植移植和功能在老鼠模型中的影响.
- 评估供体甲状腺成熟度对移植手术结果的影响.
- 根据年龄匹配,评估移植甲状腺组织的组织学和基因表达变化.
主要方法:
- 甲状腺组织从年轻 (3周大) 和已退休 (>20周大) 的老鼠中收集.
- 甲状腺移植是在年龄匹配和年龄不匹配的捐赠者-接受者对之间进行的.
- 在移植后的各种时间点,对甲状腺特异性标记物进行了组织学和基因表达特征分析.
主要成果:
- 虽然在年轻和退休老鼠甲状腺之间观察到最小的组织学差异,但退休老鼠甲状腺显示出特定甲状腺标记基因的更高表达.
- 在年龄相匹配的移植中观察到成功的移植,以及当退休的老鼠甲状腺移植到年轻的接受者身上时.
- 将年轻的小鼠甲状腺移植到已退休的接受者身上,导致毛囊结构受损和纤维变化,表明移植受损.
结论:
- 捐赠者的甲状腺成熟度和接受者的年龄是影响异构甲状腺移植成功的关键因素.
- 与受体年龄相比,供体成熟度的不匹配可能会对移植体的整合和结构产生负面影响.
- 这些发现对优化细胞和组织来源在甲状腺疾病的再生医学方法有影响.
相关概念视频
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

